C4 Therapeutics is a biopharmaceutical company focused on developing small molecule drugs that harness the body's natural processes to target and degrade disease-causing proteins. The company's innovative approach holds promise for treating a wide range of diseases, from cancer to neurodegenerative disorders. With a commitment to advancing precision medicine, C4 Therapeutics is at the forefront of revolutionizing the field of targeted protein degradation.

Refer new talent to C4 Therapeutics